Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Ani Pharmaceuticals Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +20 vs. Q4 2023
- Shares held
- 14.1M
- +495.9K (+3.6%) vs. Q4 2023
- Total value
- $975.2M
- +$224.4M (+29.9%) vs. Q4 2023
- New holders
- 42
- 65 more added
- Sold out
- 22
- 53 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 307 | $1.90B |
| Q1 2026 | 281 | $1.80B |
| Q4 2025 | 285 | $1.67B |
| Q3 2025 | 269 | $1.87B |
| Q2 2025 | 233 | $1.29B |
| Q1 2025 | 231 | $1.34B |
| Q4 2024 | 206 | $1.07B |
| Q3 2024 | 208 | $1.12B |
| Q2 2024 | 201 | $962.3M |
| Q1 2024 | 200 | $975.2M |
| Q4 2023 | 181 | $750.8M |
| Q3 2023 | 186 | $766.4M |
| Q2 2023 | 172 | $662.5M |
| Q1 2023 | 138 | $411.7M |
| Q4 2022 | 126 | $412.4M |
| Q3 2022 | 126 | $330.3M |
| Q2 2022 | 120 | $293.4M |
| Q1 2022 | 126 | $258.8M |
| Q4 2021 | 132 | $413.4M |
| Q3 2021 | 118 | $238.8M |
| Q2 2021 | 116 | $252.7M |
| Q1 2021 | 106 | $263.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StemPoint Capital LP | 0 | $0 | 0.00% | −85,382−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −51,119−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,634−100.0% | Sold out |
| Defender Capital, LLC. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Tejara Capital Ltd | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −9,355−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −8,477−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −8,500−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −8,052−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −7,210−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −5,311−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −4,318−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −4,146−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −3,862−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −3,831−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,022−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −2,725−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −2,531−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −1,056−100.0% | Sold out |
| Coppell Advisory Solutions LLC | – | – | – | – | Not filed |